Search research articles
Contact Us
Filters
Showing results (111-120 of 1,470) with videos related to
Page
of 147
Sort By:
Oncotarget
|
December 15, 2015
90 Y-ibritumomab tiuxetan: a nearly forgotten opportunityr
Patrizia Mondello, Salvatore Cuzzocrea, Michele Navarra, et al.
Thorax
|
June 2, 2006
Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis
S Greco, E Girardi, A Navarra, et al.
Peptides
|
October 2, 2010
Cortistatin modulates calcitonin gene-related peptide release from neuronal tissues of rat. Comparison with somatostatin
Alessandro Capuano, Diego Currò, Pierluigi Navarra, et al.
Neurochemistry International
|
March 11, 2017
Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm
Emilia Laudati, Diego Currò, Pierluigi Navarra, et al.
Addiction Biology
|
May 28, 2019
Novel role for cannabidiol in circadian clock function
Maurizio Bifulco, Giovanna Navarra, Chiara Laezza, et al.
Drugs Under Experimental and Clinical Research
|
January 1, 1990
Antibacterial activity of combined cefotaxime and desacetyl-cefotaxime against aerobic and anaerobic gram-negative bacilli
P Marone, A Navarra, V Monzillo, et al.
Plos One
|
November 3, 2021
The influence of personality traits on university performance: Evidence from Italian freshmen students
Luca Corazzini, Silvia D'Arrigo, Emanuele Millemaci, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 1, 1989
Serum bactericidal activity against aerobes and anaerobes of volunteers receiving cefoxitin or cefotetan
M Cruciani, A Navarra, L Bono, et al.
Oncotarget
|
January 19, 2017
Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression
Patrizia Mondello, Salvatore Cuzzocrea, Michele Navarra, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
May 1, 1991
Alpha 2-adrenoceptor-mediated inhibition of prolactin release in suckling- or fenfluramine-induced hyperprolactinemia
P Navarra, W Eechaute, P Preziosi, et al.
Page
of 147
Search research articles
Search
Showing results (111-120 of 1,470) with videos related to
Sort By:
Page
of 147
Oncotarget
|
December 15, 2015
90 Y-ibritumomab tiuxetan: a nearly forgotten opportunityr
Patrizia Mondello, Salvatore Cuzzocrea, Michele Navarra, et al.
Thorax
|
June 2, 2006
Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis
S Greco, E Girardi, A Navarra, et al.
Peptides
|
October 2, 2010
Cortistatin modulates calcitonin gene-related peptide release from neuronal tissues of rat. Comparison with somatostatin
Alessandro Capuano, Diego Currò, Pierluigi Navarra, et al.
Neurochemistry International
|
March 11, 2017
Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm
Emilia Laudati, Diego Currò, Pierluigi Navarra, et al.
Addiction Biology
|
May 28, 2019
Novel role for cannabidiol in circadian clock function
Maurizio Bifulco, Giovanna Navarra, Chiara Laezza, et al.
Drugs Under Experimental and Clinical Research
|
January 1, 1990
Antibacterial activity of combined cefotaxime and desacetyl-cefotaxime against aerobic and anaerobic gram-negative bacilli
P Marone, A Navarra, V Monzillo, et al.
Plos One
|
November 3, 2021
The influence of personality traits on university performance: Evidence from Italian freshmen students
Luca Corazzini, Silvia D'Arrigo, Emanuele Millemaci, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 1, 1989
Serum bactericidal activity against aerobes and anaerobes of volunteers receiving cefoxitin or cefotetan
M Cruciani, A Navarra, L Bono, et al.
Oncotarget
|
January 19, 2017
Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression
Patrizia Mondello, Salvatore Cuzzocrea, Michele Navarra, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
May 1, 1991
Alpha 2-adrenoceptor-mediated inhibition of prolactin release in suckling- or fenfluramine-induced hyperprolactinemia
P Navarra, W Eechaute, P Preziosi, et al.
Page
of 147